Neal Shore

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Neal Shore
May 22, 2025, 08:35 | Science
Dillon Cockrell: Targeted Therapy for mCRPC with BRCA Mutations
Dillon Cockrell, Medical Oncologist and GU Cancer Expert at Duke Cancer Center, shared an article on…
Apr 29, 2025, 10:50 | Blog
Tom Powles: Podcast with Neal Shore around the CREST RIII untreated NMIBC BCG +/- PD1 trial
Tom Powles, Professor at the University of London, shared a post on X: "Here is a…
Jan 12, 2025, 07:12 | Insight
Pfizer’s Sasanlimab with BCG Improved Event-Free Survival in High-Risk Bladder Cancer
Pfizer Inc. has announced promising topline results from its pivotal Phase 3 CREST trial, which…
Dec 29, 2024, 07:46 | Blog
Erman Akkus: Top 4 articles of JCO ASCO in 2024
Erman Akkus, Medical oncology fellow at the Ankara University, shared a post on X:  “Top…
Dec 23, 2024, 16:19 | Insight
Michael Hofman‘s top 10 publications from 2024 which ProsTic contributed to
Michael Hofman, Nuclear Medicine Physician at Melbourne’s Peter MacCallum Cancer Centre and Director of ProsTic,…
Dec 22, 2024, 12:43 | Science
Edward D. Esplin: Universal Germline Genetic Testing Standard of Care for Prostate Cancer
Edward D. Esplin, Clinical Geneticist at Invitae, shared a recent article on LinkedIn: "Universal Germline…
Dec 16, 2024, 17:43 | Blog
UroToday.com - PARP inhibitors: Targeting DNA repair pathways in mCRPC
UroToday.com shared on X: "PARP inhibitors: Targeting DNA repair pathways. Neal Shore joins Fred Saad in…
Dec 4, 2024, 15:19 | Blog
Neeraj Agarwal: Consensus statement from 2024 United States Prostate Cancer Conference
Neeraj Agarwal, Professor of Medicine and Presidential Endowed Chair of Cancer Research at the Huntsman…
Nov 30, 2024, 23:26 | Blog
Enrique Grande: SITC Guideline on Immunotherapy for Urothelial Cancer
Enrique Grande, the Head of Oncology at MD Anderson Cancer Center Madrid, shared a post…
Oct 19, 2024, 18:47 | Blog
Hannah Dzimitrowicz McManus: Navigating therapeutic sequencing in the mcRPC
Hannah Dzimitrowicz McManus, Hematology-Oncology Fellow at Duke University Health System, shared a recent article on…
Oct 2, 2024, 15:22 | Blog
We are Physicians, and the interest of patients should be our priority, summarised by Yakup Ergün
Yakup Ergün, Medical Oncologist at Bower Hospital, shared an article by Fred Saad on X:…
Aug 31, 2024, 11:09 | Blog
Edward D. Esplin: Clinician Responses to Germline Genetic Testing in Prostate Cancer Management
Edward D. Esplin, Clinical Geneticist at Invitae, shared on X: “Up to 17% of prostate…
May 14, 2024, 09:21 | Drugs
Piotr Wysocki: Pembrolizumab prevents recurrence in BCG-resistant bladder cancer
Piotr Wysocki recently posted on LinkedIn: "Necchi A et al. published a phase II single-arm study…
Apr 15, 2024, 12:07 | Blog
Neeraj Agarwal: A comprehensive review of PARPi+ARPI combos in 1st line mCRPC
Neeraj Agarwal shared a post on X: "Just in A comprehensive review of PARPi+ARPI combos…
Nov 23, 2023, 15:44 | Blog
Chandler Park: We FINALLY have an effective FDA approved practice changing treatment for OUR patients that have a rising PSA after radical prostatectomy and/or radiation treatment
All: 15 Posts: 1 - 100
Special Coverage